Immunization, Hib3 in Post-demographic dividend
Post-demographic dividend: Immunization, Hib3 was 92.8% in 2024. ▲ Rising
Immunization, Hib3 in Post-demographic dividend, 1990–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
In 2024, immunization, hib3 in Post-demographic dividend stood at 92.8%.
That represents a change of up 0.2% on the previous year and up 2.1% over ten years.
Over the whole period, immunization, hib3 in Post-demographic dividend peaked at 93.6% in 2021 and was at its lowest, 0.0%, in 1990.
Post-demographic dividend ranks 7th of 43 groups on this measure, in the top quarter.
The long-run direction has been consistently rising across the 35 years of available data.
Immunization, Hib3 in Post-demographic dividend, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1990 | 0.0% | — |
| 1991 | 5.3% | — |
| 1992 | 6.6% | +24.7% |
| 1993 | 13.1% | +97.3% |
| 1994 | 13.4% | +2.5% |
| 1995 | 43.2% | +221.2% |
| 1996 | 47.0% | +8.8% |
| 1997 | 51.6% | +9.8% |
| 1998 | 61.3% | +18.8% |
| 1999 | 65.7% | +7.2% |
| 2000 | 68.9% | +4.9% |
| 2001 | 70.4% | +2.1% |
| 2002 | 72.6% | +3.2% |
| 2003 | 73.9% | +1.7% |
| 2004 | 75.4% | +2.0% |
| 2005 | 75.7% | +0.5% |
| 2006 | 76.7% | +1.3% |
| 2007 | 78.1% | +1.9% |
| 2008 | 78.9% | +1.0% |
| 2009 | 76.0% | -3.6% |
| 2010 | 77.7% | +2.3% |
| 2011 | 87.2% | +12.3% |
| 2012 | 89.5% | +2.6% |
| 2013 | 89.0% | -0.5% |
| 2014 | 90.9% | +2.1% |
| 2015 | 90.9% | -0.0% |
| 2016 | 91.3% | +0.5% |
| 2017 | 90.7% | -0.7% |
| 2018 | 92.1% | +1.5% |
| 2019 | 92.8% | +0.8% |
| 2020 | 92.8% | -0.0% |
| 2021 | 93.6% | +0.8% |
| 2022 | 92.5% | -1.1% |
| 2023 | 92.6% | +0.1% |
| 2024 | 92.8% | +0.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 30.7% | 0.0% | 65.7% | 10 |
| 2000s | 74.7% | 68.9% | 78.9% | 10 |
| 2010s | 89.2% | 77.7% | 92.8% | 10 |
| 2020s | 92.9% | 92.5% | 93.6% | 5 |
More health data for Post-demographic dividend
- Population ages 30-34, male, annual growth rate -1.11 % change on previous year (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate 0.4277 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0323 units per person (2025)
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, female, annual growth rate 0.1565 % change on previous year (2025)
- Population ages 30-34, male, per capita 0.0327 units per person (2025)
- Population ages 30-34, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 25-29, male, annual growth rate -0.0085 % change on previous year (2025)
- Population ages 25-29, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is immunization, hib3 in Post-demographic dividend?
- Immunization, hib3 in Post-demographic dividend was 92.8% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Post-demographic dividend?
- The highest recorded value was 93.6% in 2021.
- What is the lowest immunization, hib3 recorded in Post-demographic dividend?
- The lowest recorded value was 0.0% in 1990.
- How does Post-demographic dividend rank for immunization, hib3?
- Post-demographic dividend ranks 7th out of 43 groups with data for 2024.
- Is immunization, hib3 rising or falling in Post-demographic dividend?
- Over the last ten years it is up 2.1%. The long-run trend across the full record is rising.
- Where does this Post-demographic dividend data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.